glp 1 neuroprotection Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease and Parkinson's disease | Journal of Biomedical Science Neurotrophic and neuroprotective effects of

Author contributions NK and NS conceived the idea and conceptualized the study

Sanford, was recently featured in Forbes in an article titled As Peptides Go Mainstream, Experts Say Oversight Matters. The article explores the rapid growth of peptide therapies across wellness, longevity, recovery, aesthetics, metabolism, sleep, inflammation, cognitive health, and performance optimization

The skyrocketing demand for GLP-1 weight-loss medications has led to a surge in compounding pharmacies producing similar products at lower prices, but researchers warn that these medications are not always as safe as they claim

When medication levels remain stable, your body adjusts more easily